Evolus (EOLS) Total Current Liabilities (2017 - 2026)

Evolus (EOLS) posted Total Current Liabilities of $68.0 million for Q1 2026, down 9.67% on a QoQ basis from $75.3 million in Q4 2025, and up 20.97% year-over-year from $56.2 million in Q1 2025.

Evolus (EOLS) Total Current Liabilities (2017 - 2026) Analysis & Trends

Evolus' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $68.0 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 20.97% year-over-year to $68.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.0 million (up 20.97% YoY) and the FY2025 annual result came in at $75.3 million, up 19.61% from the prior year.
  • Total Current Liabilities was $68.0 million for Q1 2026 at Evolus, down from $75.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $75.3 million in Q4 2025 and bottomed at $40.7 million in Q1 2023.
  • A 5-year average of $54.3 million and a median of $51.5 million in 2022 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities plunged 53.56% — and 2024, when it surged 30.88%.
  • Evolus' Total Current Liabilities stood at $46.5 million in 2022, then gained by 3.83% to $48.3 million in 2023, then jumped by 30.38% to $63.0 million in 2024, then climbed by 19.61% to $75.3 million in 2025, then decreased by 9.67% to $68.0 million in 2026.
  • Business Quant data shows EOLS's Total Current Liabilities at $68.0 million in Q1 2026, $75.3 million in Q4 2025, and $66.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn 68.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68.02 Mn
Dec 31, 2025 75.31 Mn
Sep 30, 2025 66.71 Mn
Jun 30, 2025 63.75 Mn
Mar 31, 2025 56.23 Mn
Dec 31, 2024 62.96 Mn
Sep 30, 2024 60.82 Mn
Jun 30, 2024 54.12 Mn
Mar 31, 2024 46.80 Mn
Dec 31, 2023 48.29 Mn
Sep 30, 2023 48.54 Mn
Jun 30, 2023 41.35 Mn
Mar 31, 2023 40.68 Mn
Dec 31, 2022 46.51 Mn
Sep 30, 2022 51.27 Mn
Jun 30, 2022 51.53 Mn
Mar 31, 2022 40.70 Mn
Dec 31, 2021 57.66 Mn
Sep 30, 2021 71.30 Mn
Jun 30, 2021 87.29 Mn